NCT05182255View on ClinicalTrials.gov

Post Market Clinical Study - Evolution® Esophageal Stent Systems, Europe: Fully and Partially Covered

CompletedOBSERVATIONAL
Enrollment

127

Participants

Timeline

Start Date

April 28, 2022

Primary Completion Date

December 8, 2023

Study Completion Date

December 8, 2023

Conditions
Esophageal Diseases
Interventions
DEVICE

Evolution® Esophageal Stent Systems, Europe: Fully and Partially Covered

To aid in maintaining patency of the esophagus in cases of obstruction of the esophagus caused by an esophageal disease and to seal tracheoesophageal fistula.

Trial Locations (5)

40217

Evangelisches Krankenhaus Düsseldorf, Düsseldorf

86156

Universitatsklinikum Augsburg, Augsburg

370007

Hospital Universitario de Salamanca, Salamanca

04600

Klinikum Altenburg, Altenburg

NW1 2BU

University College London, London

All Listed Sponsors
lead

Cook Research Incorporated

INDUSTRY